Home › Funds › GordonMD Global Investments LP › TSHA
GordonMD Global Investments LP position in TSHA
TAYSHA GENE THERAPIES INC · Health Care
GordonMD Global Investments LP reported holding 248,000 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q3 2026 13F filing — a position valued at US$6.2M, representing 3.72% of its reported portfolio and ranking #12 among its reported holdings. GordonMD Global Investments LP has disclosed TSHA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GordonMD Global Investments LP's TSHA position evolved
GordonMD Global Investments LP first disclosed a stake in TSHA in Q4 2025 at 1,330,901 shares (US$7.3M). The position peaked in Q2 2026 at 723,185 shares, worth US$24.5M. Across 4 filings, GordonMD Global Investments LP increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 248,000 shares valued at US$6.2M — a reduction of -475,185 shares quarter over quarter.. Notable position changes include a 45% trim in Q1 2026 (shares rose 52% over the following quarter), a 66% trim in Q3 2026 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.33M | $7.32M | New |
| Q1 2026 | 737.55K | $22.22M | Reduce |
| Q2 2026 | 723.18K | $24.50M | Reduce |
| Q3 2026 | 248.00K | $6.19M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TSHA and 13F data
TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 47 other funds we track also report a position in TSHA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M), Avoro Capital Advisors LLC (US$116.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TSHA
- RA CAPITAL MANAGEMENT, L.P. 23.56M sh · $160.41M · Q2 2026
- Vestal Point Capital, LP 19.41M sh · $132.22M · Q2 2026
- Avoro Capital Advisors LLC 23.89M sh · $116.34M · Q3 2026
- RTW INVESTMENTS, LP 13.56M sh · $66.04M · Q3 2026
- Octagon Capital Advisors LP 9.69M sh · $66.01M · Q2 2026
- Siren, L.L.C. 9.85M sh · $47.95M · Q3 2026
- MPM BioImpact LLC 4.50M sh · $30.64M · Q2 2026
- BAKER BROS. ADVISORS LP 4.00M sh · $27.27M · Q2 2026
- Casdin Capital 3.25M sh · $22.13M · Q2 2026
- ADAR1 Capital Management, LLC 3.06M sh · $14.90M · Q3 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 1.50M sh · $10.21M · Q2 2026
- Seven Fleet Capital Management LP 1.50M sh · $9.94M · Q2 2026
More on GordonMD Global Investments LP
FAQ
How long has GordonMD Global Investments LP held TSHA?
GordonMD Global Investments LP has disclosed TSHA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is GordonMD Global Investments LP's current position in TSHA?
As of Q3 2026, GordonMD Global Investments LP holds 248.00K shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $6.19M, representing 3.72% of its reported portfolio and ranking #12.
Has GordonMD Global Investments LP been buying or selling TSHA?
In the latest 13F filing (Q3 2026), GordonMD Global Investments LP reduced its position in TSHA. The position peaked in Q2 2026 at 723.18K shares.
Which other funds hold TSHA?
Other major institutional holders of TSHA include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Avoro Capital Advisors LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.